Barclays
DNMR

Barclays’s Danimer Scientific, Inc. DNMR Stock Holding History

Barclays’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8
Closed -$139 – 5558
2024
Q3 		$139 Sell
8
-1,384
-99% -$24.2K ﹤0.01% 5175
2024
Q2 		$33.6K Sell
1,392
-138
-9% -$4.29K ﹤0.01% 4338
2024
Q1 		$66.7K Sell
1,530
-1,478
-49% -$61.2K ﹤0.01% 4552
2023
Q4 		$123K Buy
3,008
+2,632
+700% +$143K ﹤0.01% 4585
2023
Q3 		$31.1K Sell
376
-138
-27% -$12.5K ﹤0.01% 4044
2023
Q2 		$48.9K Sell
514
-639
-55% -$82K ﹤0.01% 3846
2023
Q1 		$159K Buy
1,153
+545
+90% +$49.8K ﹤0.01% 3924
2022
Q4 		$43.6K Buy
608
+509
+514% +$48.1K ﹤0.01% 4597
2022
Q3 		$11K Sell
99
-271
-73% -$48.3K ﹤0.01% 4284
2022
Q2 		$68K Sell
370
-286
-44% -$52K ﹤0.01% 3927
2022
Q1 		$158K Buy
+656
New +$132K ﹤0.01% 3561

Other funds holding DNMR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Barclays's DNMR Position: Q4 2024 in Review

Barclays sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 8 shares — an estimated $139 sold.

Barclays first reported a position in DNMR in Q1 2022 and held it in 11 quarters. The position peaked at $159K in Q1 2023. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Barclays reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Barclays sold 8 Danimer Scientific, Inc. shares in Q4 2024, an estimated $139.
  • Barclays first reported a position in Danimer Scientific, Inc. in Q1 2022 and held it in 11 quarters.
  • Barclays's Danimer Scientific, Inc. position peaked at $159K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Barclays's 13F filing for Q4 2024, filed 13 Feb 2025.